Other examples of potential functional interactions might include the receptor for long-chain saturated fatty acids, FFA1, which is also expressed in pancreatic beta cells, where its activation leads to GSIS potentiation via G q transducer pathways (Secor et al., 2021) and enteroendocrine L and K cells, where it contributes to incretin hormone secretion, with FFA1 KO mice exhibiting obesity on a low-fat diet (Lu et al., 2021)
ApoE status (if tested)
For more effective and efficient medication delivery, these NPs can be functionalized with certain ligands or antibodies to target cells or tissues in the body
This prolonged contact can increase the likelihood of experiencing common side effects like: Nausea or sour stomach Abdominal pain or cramping Indigestion or heartburn For most people, a single dose of ibuprofen occasionally will not cause a major issue
Phase 3 Update: TRIUMPH-4 Results Preliminary data from the ongoing Phase 3 TRIUMPH-4 trial (68 weeks) shows higher numbers than Phase 2: 12mg dose: 28.7% average weight loss (~71 lbs / 32 kg) 9mg dose: 26.4% average weight loss (~64 lbs / 29 kg) Knee osteoarthritis pain: 76% reduction (significant quality-of-life improvement) Blood pressure: Average reduction of 14 mmHg Full Phase 3 results across the TRIUMPH program (obesity, diabetes, cardiovascular outcomes, kidney outcomes) are expected throughout 2026
Its not, its something else. And that something else is none of anyones business, Goldberg affirmed